Cancer is one of the leading causes of death worldwide and remains a major public health
challenge. The introduction of more sensitive and powerful technologies has permitted the …

Liquid biopsy is emerging as a pivotal tool in precision oncology, offering a noninvasive and
comprehensive approach to cancer diagnostics and management. By harnessing biofluids …

Liquid biopsy (LB) is a minimally invasive method which aims to detect circulating tumor-
derived components in body fluids. It provides an alternative to current cancer screening …

At least 5% of cancer diagnoses are attributed to a causal pathogenic or likely pathogenic
germline genetic variant (hereditary cancer syndrome—HCS). These individuals are …

The use of molecular techniques in the bioanalytical laboratory is becoming more common
as the number of gene and cell therapy products continues to increase. Currently, there is no …

Recently, long noncoding RNAs (lncRNAs) have been applied as biomarkers for melanoma
patients. In this systematic review and meta‐analysis, we investigated the diagnostic and …

Background Operable stage I-III non-small cell lung cancer (NSCLC) has a high risk of
recurrence, mainly due to remnant clones of the disease defined as minimal residual …

Advancements in genetic sequencing techniques along with the identification of specific
mutations and structural changes in multiple cancer genes, make it possible to identify …

The molecular profiling of circulating tumor DNA (ctDNA) is a helpful tool not only in cancer
treatment, but also in the early detection of relapse. However, the clinical interpretation of a …

Cancer is becoming a global pandemic, and its occurrence is increasing rapidly, putting a
strain on people's families, health systems, and finances, in addition to their physical …